Session Information
-
WCLC 2022
2022 World Conference on Lung Cancer
Conference Program for 2022 the World Conference on Lung Cancer
Presentation Date(s):- August 6 - 9, 2022
- Total Presentations: 2137
All times listed are in Vienna, Austria Time, CEST (UTC+2:00)
PL - Plenary
IBS - Interactive Breakfast Session (in-person attendees only)
ES - Education Session
OA - Oral Session
MA - Mini Oral Session
P - Posters
EP - ePosters
WS - Workshops
LA – Lectureship Awards
IS - Industry Symposium
August 5 Fri
Aug 5 Saturday
August 6 Sat
Aug 6 Sunday
August 7 Sun
Aug 7 Monday
August 8 Mon
Aug 8 Tuesday
August 9 Tue
Aug 9
-
+
WS08 - Joint IASLC-CSCO-CAALC Session: Liquid Biopsy in Oncogene Driven NSCLC (On-demand)
- 21:00 - 23:59
- 8/06/2022
- Location: On-Demand
- Not for CME Credit
- Type: Workshop
- Track: N/A
- Moderators:Yi-Long Wu, Chunxue Bai, Caicun Zhou, Karen Kelly
-
+
WS08.23 - Transcriptomic Heterogeneity in Non-Small Cell Lung Cancer with Four Structure-Based EGFR-Mutation Subgroups
23:44 - 23:45 | Presenter: Shun Lu | Author(s): LinPing Gu, Yongfeng Yu, Lan Shen, Fei Yao, Changbin Zhu, Jin Wang
- Abstract
Loading...
-
+
OA03 - Molecular Targeted Treatments
- 14:30 - 15:40
- 8/07/2022
- Location: Hall C7
- Not for CME Credit
- Type: Oral
- Track: Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
- Moderators:Andrew Ciupek, David R. Gandara
-
+
OA03.07 - Safety and Efficacy of D-1553 in Patients with KRAS G12C Mutated Non-Small Cell Lung Cancer: A Phase 1 Trial
15:12 - 15:22 | Presenter: Shun Lu | Author(s): Hong Jian, Yiping Zhang, Zhengbo Song, Yanqiu Zhao, Pingli Wang, Liyan Jiang, Yi Gong, Jianying Zhou, Xiaorong Dong, Nong Yang, Jian Fang, Wu Zhuang, Shundong Cang, Rui Ma, Jianhua Shi, Ping Wu, Junguo Lu, Ziyong Xiang, Zhe Shi, Ling Zhang, Yaolin Wang
- Abstract
Loading...
-
+
EP08.01 - Metastatic Non-small Cell Lung Cancer - Immunotherapy
- 09:45 - 18:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: E-Poster
- Track: Metastatic Non-small Cell Lung Cancer - Immunotherapy
-
+
EP08.01-009 - TRBV Haplotype Profile Was Related to Immune-Induced Adverse Events in Chinese Patients With Advanced NSCLC
Presenter: Xiaomin Niu | Author(s): Ying Wang, Liliang Xia, Mian Xu, Weirong Zhao, Feng Li, Shun Lu- Abstract
Loading... -
+
EP08.01-073 - AdvanTIG-105: Phase 1b Dose-Expansion Study of Ociperlimab plus Tislelizumab in Patients with Metastatic NSCLC
Presenter: Rajiv Kumar | Author(s): Se Hyun Kim, Diansheng Zhong, Shun Lu, Ying Cheng, Ming Chen, EunKyung Cho, Tim Clay, Jin-Hyoung Kang, Gyeong-Won Lee, Meili Sun, Byoung Yong Shim, David Spigel, Tsung-Ying Yang, Qiming Wang, Gee-Chen Chang, GuoHua Yu, Ruihua Wang, Xuerui Luo, Hao Zheng, Rang Gao, Hye Ryun Kim- Abstract
Loading... -
+
EP08.01-081 - A Phase I Dose-Escalation Study of HBM4003, an anti-CTLA-4 Heavy Chain Only Monoclonal Antibody, in Combination with Pembrolizumab
Presenter: Shun Lu | Author(s): Meili Sun, Luyin Ding, Jinfeng Ji, Dian Yang, Xin Gan, Yuansheng Zhao, Xi Liu, Xiaoxiang Chen- Abstract
Loading... -
+
EP08.01-082 - Therapeutic Resistance and Clonal Evolution Assessed With Liquid Biopsy in ICIs Treated NSCLC Patients: A Prospective Study
Presenter: Shun Lu | Author(s): Xinghao Ai, Minglei Zhuo, Junping Zhang, Jiexia Zhang, Jun Zhao, Mingfeng Huang, Rongrong Chen- Abstract
Loading...
-
+
EP08.02 - Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
- 09:45 - 18:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: E-Poster
- Track: Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
-
+
EP08.02-064 - ASTRIS China: A Real-world Study of Osimertinib in Patients with EGFR T790M Positive Non-small-cell Lung Cancer (NSCLC)
Presenter: Qing Zhou | Author(s): He-Long Zhang, Li-Yan Jiang, Yuankai Shi, Yuan Chen, Jin-Ming Yu, Caicun Zhou, Yong He, Yan-Ping Hu, Zong-An Liang, Yue-Yin Pan, Wen-Lei Zhuo, Yong Song, Gang Wu, Gong-Yan Chen, You Lu, Cui-Ying Zhang, Yi-Ping Zhang, Ying Chen, Shun Lu, Yi-Long Wu- Abstract
Loading... -
+
EP08.02-137 - Prospective Study of Aumolertinib in NSCLC Patients with EGFR Sensitive Mutations Who Are Intolerant to Osimertinib Treatment
Presenter: Shun Lu- Abstract
Loading... -
+
EP08.02-138 - SAFFRON: Ph3 Savolitinib + Osimertinib vs Chemotherapy in EGFRm NSCLC with MET Overexpression/Amplification Post-Osimertinib
Presenter: Shun Lu | Author(s): Wanning Xu, Aino Telaranta-Keerie, Nan Jia, Ryan Hartmaier- Abstract
Loading... -
+
EP08.02-139 - A Phase 2 Study of Befotertinib in Patients with EGFR T790M Mutated NSCLC after Prior EGFR TKIs
Presenter: Shun Lu | Author(s): Yiping Zhang, Guojun Zhang, Jianying Zhou, Shundong Cang, Ying Cheng, Gang Wu, Peiguo Cao, Dongqing Lv, Hong Jian, Chengshui Chen, Xiangming Jin, Panwen Tian, Kai Wang, Guanming Jiang, Gongyan Chen, Qun Chen, Hui Zhao, Cuimin Ding, Renhua Guo, Guoping Sun, Bin Wang, Liyan Jiang, Zhe Liu, Jian Fang, Junquan Yang, Wu Zhuang, Yunpeng Liu, Jian Zhang, YueYin Pan, Jun Chen, Qitao Yu, Min Zhao, Jiuwei Cui, Dianming Li, Tienan Yi, Zhuang Yu, Yan Yang, Yan Zhang, Xiuyi Zhi, Yunchao Huang, Rong Wu, Liangan Chen, Aimin Zang, Lejie Cao, Qingshan Li, Xiaoling Li, Yong Song, Donglin Wang, Shucai Zhang- Abstract
Loading...
-
+
EP08.03 - Metastatic Non-small Cell Lung Cancer - Oligometastatic Disease
- 09:45 - 18:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: E-Poster
- Track: Metastatic Non-small Cell Lung Cancer - Oligometastatic Disease
-
+
EP08.03-008 - Whether Immunotherapy Should Be Maintained or Not After Acquired Resistance in Advanced Nsclc
Presenter: Shun Lu | Author(s): Huayan Huang, Zhangwendi Xu, Yongfeng Yu- Abstract
Loading...
-
+
EP16.03 - Tumor Biology and Biomarkers - Molecular Profiling and Targeted Therapeutics
- 09:45 - 18:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: E-Poster
- Track: Tumor Biology and Biomarkers - Molecular Profiling and Targeted Therapeutics
-
+
EP16.03-031 - Transcriptomic Heterogeneity in Non-Small Cell Lung Cancer Harboring Different EGFR Exon 19 Del/Delins Variants
Presenter: Shun Lu | Author(s): Linping GU, Yongfeng Yu, Lan Shen, Fei Yao, Changbin Zhu, Jin Wang- Abstract
Loading... -
+
EP16.03-032 - Structure-Based Classification of Chinese Patients with Non-Canonical EGFR-Mutant Non-Small Cell Lung Cancer
Presenter: Shun Lu | Author(s): Linping GU, Yongfeng Yu, Lan Shen, Fei Yao, Changbin Zhu, Jin Wang- Abstract
Loading... -
+
EP16.03-033 - Transcriptomic Heterogeneity in Non-Small Cell Lung Cancer with Four Structure-Based EGFR-Mutation Subgroups
Presenter: Shun Lu | Author(s): Linping GU, Yongfeng Yu, Lan Shen, Fei Yao, Changbin Zhu, Jin Wang- Abstract
Loading... -
+
EP16.03-044 - Genomic Evidence Depicting Clonal Evolution of Lung Adenosquamous Carcinoma
Presenter: Yuchen Han | Author(s): Shun Lu, Ruiying Zhao, Yunhua Xu, Yedan Chen, Chan Xiang, Qian Wu, Shengnan Chen, Jiaohui Pang, zhanxian Shang, Jikai Zhao, Hairong Bao, Yang Shao- Abstract
Loading...
-
+
OA11 - Optimal Patient Selection for Local Therapy in Stage IV NSCLC
- 16:00 - 17:00
- 8/08/2022
- Location: Hall C7
- Not for CME Credit
- Type: Oral
- Track: Metastatic Non-small Cell Lung Cancer - Oligometastatic Disease
- Moderators:Pablo Munoz-Schuffenegger, Mariana Brandao
-
+
OA11.05 - Treatment Strategies Based on Different Oligoprogressive Patterns after Immunotherapy Resistance in Advanced NSCLC
16:22 - 16:32 | Presenter: Shun Lu | Author(s): Zhangwendi Xu, Huayan Huang, Yongfeng Yu
- Abstract
Loading...
